3 Magnificent Mutual Funds to Maximize Your Retirement Portfolio
Consider adding these three top-ranked, best-performing and well-managed mutual funds to your retirement portfolio if you are looking to maximize returns.
Consider adding these three top-ranked, best-performing and well-managed mutual funds to your retirement portfolio if you are looking to maximize returns.
Consider adding these three top-ranked, best-performing and well-managed mutual funds to your retirement portfolio if you are looking to maximize returns.
Take advantage of these top-ranked, best-performing and well-managed mutual funds to maximize your retirement portfolio returns.
- The small-cap ETF is struggling, causing investors to head for the exits. - The exodus, combined with deep losses, has slashed the fund’s assets by nearly half.
CVX stock has come under pressure in recent months as legal hurdles, Venezuela losses, and falling EPS estimates weigh on its outlook.
CRISPR Therapeutics has the potential to generate significant breakthroughs in gene editing. Regeneron's biggest growth driver is still performing well, and it is developing newer medicines. For investors still seeking companiies with attractive long-term prospects, let's consider two in the biotech industry: CRISPR Therapeutics (NASDAQ: CRSP) and Regeneron Pharmaceuticals (NASDAQ: REGN).
Tech giants like INTU, APH, AVGO, TWLO and UI surged over 11% in May, powering markets past the "Sell in May" adage with standout gains.
LEVI, LE, ULTA, TGT, and DECK are under the spotlight as Zacks questions whether beaten-down retail stocks are values or traps.
THNR hits a 52-week high, fueled by gains in Eli Lilly and Novo Nordisk -- could the rally still have legs?
Mutual Fund Report for MPGFX